Q4FY16 Results: Sanofi India

Sanofi India Ltd. reported its standalone results for the quarter ended December 31, 2016 today.

The company reported sales of Rs 592 crore for Q4FY16, which represents a 5.13 per cent sequential decline and 4.1 per cent YoY increase.

Its operating profit (EBIT) for the quarter amounted was Rs. 66.1 crore and its EBIT margin stood at 11.17 per cent.

The company reported PAT of Rs 50.5 crore, which represents a sequential QoQ decline of 37.34 per cent and a YoY decline of 3.81 per cent.

The company's stock opened at Rs 4138.65 on the BSE, rose 0.46 per cent and closed for the day at Rs 4157.85.

Sanofi Inida Ltd. is an Indian pharmaceutical company. The company's product portfolio includes medicines for several therapeutic areas including cardiovascular, thrombotic, metabolic disorders, oncology, disorders of the central nervous system, internal medicine.